CTOs on the Move

SaluGenecists Inc

www.salugenecists.com

 
SaluGenecists Inc is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Camtech Inc

Camtech Inc is a New Palestine, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Eastern Shore Rural Health

Serving Virginia's Eastern Shore with five medical centers and four dental locations from Chincoteague Island to Cape Charles, Eastern Shore Rural Health System, Inc. (ESRHS), is the medical provider of choice for more than half the Eastern Shore community's population. All ESRHS centers are open Monday - Friday with evening hours available including 10-hour days at the Onley center. ESRHS is open on Saturday mornings year-round at the Onley center and seasonally at Chincoteague.   In addition to primary medical and dental services, ESRHS offers health education, pharmacy assistance, digital x-ray, labwork, travel immunizations and much, much more. In partnership with the Chesapeake Bay Bridge-Tunnel, ESRHS is able to offer toll passes for qualifying residents who have a medical visit with a specialist. ESRHS' electronic health records system means you can be seen at any ESRHS center and the staff will have your complete medical history.   ESRHS' highly qualified clinicians offer compassionate, dedicated care for their patients. At ESRHS you are more than just a medical chart, you're a part of a family-oriented medical home.   In one year's time 28,483 people chose one of Rural Health's five medical locations or four dental locations for their healthcare needs. We provided 92,712 medical and 13,606 dental visits. This past fiscal year, 29% of Rural Health patients had private insurance; 19% had Medicaid; 14% had Medicare; and 38% were uninsured.

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.

Kinerase

Kinerase is a Aliso Viejo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Brownsboro Park Retirement Community

Brownsboro Park Retirement Community is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.